High materiality7/10
Rigel Pharmaceuticals price target raised to $49 from $40 at Piper Sandler
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raises RIGL target to $49; current price $42.58. Signals upside potential.
- Target $49 vs price $42.58; bullish.
Key facts
- 01
Target: $49
- 02
Posted price: $42.58
- 03
Analyst firm: Piper Sandler
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.